Related Experiment Videos

[Atrial flutter in neonates and infants: diagnosis and treatment]

Fatma Ouarda1, Héla M'Saad, Lilia Chaker

  • 1Service de Cardiologie Pédiatrique, Hôpital la Rabta, Tunis.

La Tunisie Medicale
|April 1, 2003
PubMed

Insights

Atrial flutter in neonates and infants is a rare but serious condition. While some infants responded to treatment, two neonates died, highlighting the condition's severity.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Arrhythmia
  • Cardiac Electrophysiology

Context:

  • Atrial flutter is a rare supraventricular tachyarrhythmia.
  • Diagnosis and management in neonates and infants present unique challenges.
  • Limited data exists on atrial flutter in this specific pediatric population.

Purpose:

  • To describe the clinical characteristics, management, and outcomes of atrial flutter in neonates and infants.
  • To evaluate the efficacy of cardioversion and amiodarone in treating pediatric atrial flutter.
  • To highlight the rarity and seriousness of atrial flutter diagnosed in the neonatal period.

Summary:

  • Five patients (3 infants, 2 neonates) were treated for atrial flutter.
  • Diagnosis was confirmed via 12-lead electrocardiogram; all patients had structurally normal hearts.
  • Cardioversion was successful in 3 patients; amiodarone showed good impregnation in 2.
  • Two neonates died within 10 days of life; one infant experienced recurrent episodes.
  • The underlying mechanism of atrial flutter in fetuses, neonates, and infants remains unknown.

Impact:

  • This study underscores the critical nature of atrial flutter in the neonatal period.
  • Findings suggest a need for further research into the pathophysiology and optimal treatment strategies.
  • Early diagnosis and intervention are crucial for improving outcomes in affected infants.

Related Concept Videos